Published in Biophys Rev on August 25, 2009
Salt-induced co-operative conformational change of a synthetic DNA: equilibrium and kinetic studies with poly (dG-dC). J Mol Biol (1972) 10.81
DNA and its associated processes as targets for cancer therapy. Nat Rev Cancer (2002) 4.69
DNA modification and cancer. Annu Rev Biochem (1981) 3.67
Sequence and structural selectivity of nucleic acid binding ligands. Biochemistry (1999) 2.54
The anti-gene strategy: control of gene expression by triplex-forming-oligonucleotides. Anticancer Drug Des (1991) 1.81
The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. J Biol Chem (2005) 1.31
Electrostatic contributions to heat capacity changes of DNA-ligand binding. Biophys J (1998) 1.31
Sanguinarine causes cell cycle blockade and apoptosis of human prostate carcinoma cells via modulation of cyclin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Mol Cancer Ther (2004) 1.17
Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin Cancer Res (2000) 1.16
DNA-intercalating ligands as anti-cancer drugs: prospects for future design. Anticancer Drug Des (1989) 1.15
Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Res (2007) 1.06
Evidence for Hoogsteen GC base pairs in the proton-induced transition from right-handed to left-handed poly(dG-dC).poly(dG-dC). Biochemistry (1997) 1.05
In vitro antifungal properties of mouthrinses containing antimicrobial agents. J Periodontol (1997) 1.04
The binding of analogues of coralyne and related heterocyclics to DNA triplexes. Biochem Cell Biol (1995) 1.01
Sanguinarine: a monofunctional intercalating alkaloid. FEBS Lett (1982) 1.00
DNA-binding affinities and sequence selectivity of quaternary benzophenanthridine alkaloids sanguinarine, chelerythrine, and nitidine. Bioorg Med Chem (2006) 0.95
Antimicrotubule properties of benzophenanthridine alkaloids. Biochemistry (1993) 0.94
Molecular aspects on the interaction of protoberberine, benzophenanthridine, and aristolochia group of alkaloids with nucleic acid structures and biological perspectives. Med Res Rev (2007) 0.93
Does DNA acid fixation produce left-handed Z structure? FEBS Lett (1995) 0.90
Differential effect of sanguinarine, chelerythrine and chelidonine on DNA damage and cell viability in primary mouse spleen cells and mouse leukemic cells. Cell Biol Int (2007) 0.90
Sanguinarine, a new antiplaque agent: retention and plaque specificity. J Am Dent Assoc (1984) 0.89
Cytotoxic benzophenanthridine and benzylisoquinoline alkaloids from Argemone mexicana. Z Naturforsch C (2003) 0.88
Sequence-selective, pH-dependent binding to DNA of benzophenanthridine alkaloids. J Mol Recognit (1990) 0.87
Base protonation facilitates B-Z interconversions of poly(dG-dC) X poly(dG-dC). Biochemistry (1984) 0.86
Effects of sanguinarine and chelerythrine on the cell cycle and apoptosis. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub (2006) 0.86
Clinicoepidemiological, toxicological, and safety evaluation studies on argemone oil. Crit Rev Toxicol (1997) 0.86
Inhibition of topoisomerase I function by nitidine and fagaronine. Chem Res Toxicol (1994) 0.86
In vitro assessment of cytotoxic agent combinations for hormone-refractory prostate cancer treatment. Anticancer Drugs (2005) 0.85
Effects of root extracts of Fagara zanthoxyloides on the in vitro growth and stage distribution of Plasmodium falciparum. Antimicrob Agents Chemother (2005) 0.84
Disruption of nucleocytoplasmic trafficking of cyclin D1 and topoisomerase II by sanguinarine. BMC Cell Biol (2006) 0.84
Spectroscopic and thermodynamic studies on the binding of sanguinarine and berberine to triple and double helical DNA and RNA structures. J Biomol Struct Dyn (2003) 0.84
DNA polymorphism under the influence of low pH and low temperature. J Biomol Struct Dyn (1994) 0.83
Sanguinarine cytotoxicity on mouse melanoma K1735-M2 cells--nuclear vs. mitochondrial effects. Biochem Pharmacol (2008) 0.82
Synthesis and cytotoxic activity of benzo[c][1,7] and [1,8]phenanthrolines analogues of nitidine and fagaronine. Bioorg Med Chem (2004) 0.82
Interaction of sanguinarine iminium and alkanolamine form with calf thymus DNA. Biochem Pharmacol (1994) 0.82
Influence of DNA structures on the conversion of sanguinarine alkanolamine form to iminium form. J Biomol Struct Dyn (2002) 0.81
Interaction of sanguinarine with natural and synthetic deoxyribonucleic acids. Indian J Biochem Biophys (1984) 0.81
Fluorescence properties of selected benzo[c]phenantridine alkaloids and studies of their interaction with CT DNA. Anal Bioanal Chem (2009) 0.80
Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage. Arch Biochem Biophys (1999) 0.80
Conversions of the left-handed form and the protonated form of DNA back to the bound right-handed form by sanguinarine and ethidium: a comparative study. Biophys Chem (1999) 0.79
Binding of sanguinarine to deoxyribonucleic acids of differing base composition. Biochem Pharmacol (1985) 0.79
Spectrometric studies of cytotoxic protoberberine alkaloids binding to double-stranded DNA. Bioorg Med Chem (2005) 0.79
Synthesis, DNA-binding affinities, and binding mode of berberine dimers. Bioorg Med Chem (2005) 0.78
Spectroscopic studies on the interaction of aristololactam-beta-D-glucoside with DNA and RNA double and triple helices: A comparative study. Biochemistry (1999) 0.78
Interaction of the antileukemic alkaloid, 2-hydroxy-3,8,9-trimethoxy-5-methylbenzo[c]phenanthridine (fagaronine), with nucleic acids. Chem Biol Interact (1983) 0.78
1H NMR investigation of the interaction of berberine and sanguinarine with DNA. Indian J Biochem Biophys (1995) 0.78
Thermodynamics of the interactions of sanguinarine with DNA: influence of ionic strength and base composition. Biophys Chem (1996) 0.77
Synthesis and evaluation of new 6-amino-substituted benzo[c]phenanthridine derivatives. J Med Chem (1993) 0.77
DNA adduct formation from quaternary benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine as revealed by the 32P-postlabeling technique. Chem Biol Interact (2002) 0.77
Evaluation of the affinity of new N atom-containing tumor inhibitors for nucleic acids. Nucleic Acids Symp Ser (1985) 0.76
Circular dichroism of sanguinarine-DNA complexes: effect of base composition, pH and ionic strength. J Biomol Struct Dyn (1987) 0.76
Comparative effects of fagaronine, adriamycin and aclacinomycin on K562 cell sensitivity to natural-killer-mediated lysis. Lack of agreement between alteration of transferrin receptor and CD15 antigen expressions and induction of resistance to natural killer. Cancer Immunol Immunother (1989) 0.76
Molecular aspects on the interaction of sanguinarine with B-form, Z-form and HL-form DNA structures. Indian J Biochem Biophys (2001) 0.76
Cytotoxicity of sanguinarine chloride to cultured human cells from oral tissue. Pharmacol Toxicol (1996) 0.76